SPOP

Disambiguation: For the animated series see She-Ra: Princess of Power.
Speckle-type POZ protein

PDB rendering based on 2cr2.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols SPOP ; BTBD32; TEF2
External IDs OMIM: 602650 MGI: 1343085 HomoloGene: 68354 GeneCards: SPOP Gene
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 8405 20747
Ensembl ENSG00000121067 ENSMUSG00000057522
UniProt O43791 Q6ZWS8
RefSeq (mRNA) NM_001007226 NM_025287
RefSeq (protein) NP_001007227 NP_079563
Location (UCSC) Chr 17:
49.6 – 49.68 Mb
Chr 11:
95.41 – 95.49 Mb
PubMed search

Speckle-type POZ protein is a protein that in humans is encoded by the SPOP gene.[1][2][3]

This gene encodes a protein that may modulate the transcriptional repression activities of death-associated protein 6 (DAXX), which interacts with histone deacetylase, core histones, and other histone-associated proteins. In mouse, the encoded protein binds to the putative leucine zipper domain of macroH2A1.2, a variant H2A histone that is enriched on inactivated X chromosomes. The BTB/POZ domain of this protein has been shown in other proteins to mediate transcriptional repression and to interact with components of histone deacetylase co-repressor complexes. Alternative splicing of this gene results in multiple transcript variants encoding the same protein.[3]

Clinical relevance

Mutations in SPOP lead to a type of prostate tumor thought to be involved in about 15% of all prostate cancers.[4][5]

References

  1. Nagai Y, Kojima T, Muro Y, Hachiya T, Nishizawa Y, Wakabayashi T, Hagiwara M (Nov 1997). "Identification of a novel nuclear speckle-type protein, SPOP". FEBS Letters 418 (1-2): 23–6. doi:10.1016/S0014-5793(97)01340-9. PMID 9414087.
  2. Zapata JM, Pawlowski K, Haas E, Ware CF, Godzik A, Reed JC (Jun 2001). "A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains". The Journal of Biological Chemistry 276 (26): 24242–52. doi:10.1074/jbc.M100354200. PMID 11279055.
  3. 1 2 "Entrez Gene: SPOP speckle-type POZ protein".
  4. Heidi Evans (20 May 2012). "Scientists find new type of prostate cancer - discovery may lead to tailored treatments". New York Daily News. Retrieved 20 May 2012.
  5. Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van Allen E, Stransky N, Nickerson E, Chae SS, Boysen G, Auclair D, Onofrio RC, Park K, Kitabayashi N, MacDonald TY, Sheikh K, Vuong T, Guiducci C, Cibulskis K, Sivachenko A, Carter SL, Saksena G, Voet D, Hussain WM, Ramos AH, Winckler W, Redman MC, Ardlie K, Tewari AK, Mosquera JM, Rupp N, Wild PJ, Moch H, Morrissey C, Nelson PS, Kantoff PW, Gabriel SB, Golub TR, Meyerson M, Lander ES, Getz G, Rubin MA, Garraway LA (Jun 2012). "Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer". Nature Genetics 44 (6): 685–9. doi:10.1038/ng.2279. PMC 3673022. PMID 22610119.

Further reading

This article is issued from Wikipedia - version of the Sunday, December 06, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.